SATIOGEN PHARMACEUTICALS INC has a total of 24 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States, EPO (European Patent Office) and United Kingdom. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are OYSTER POINT PHARMA INC, SQUIRES MERYL and BORYUNG PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | United Kingdom | 3 | |
#4 | Japan | 3 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Heterocyclic compounds | |
#5 | Implantable devices | |
#6 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Gedulin Bronislava | 22 |
#2 | Greene Howard E | 20 |
#3 | Young Andrew A | 19 |
#4 | Young Andrew | 3 |
#5 | Greene Howard | 2 |
#6 | Ayling Robert | 1 |
#7 | Yurek Matthew | 1 |
#8 | Bronislava Gedulin | 1 |
#9 | Greene Jr Howard E | 1 |
Publication | Filing date | Title |
---|---|---|
US2013090590A1 | Methods and Apparatus for Treating Obesity and Diabetes | |
EP3593802A2 | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions | |
US2011152204A1 | Treatment of Obesity or Diabetes with Bile Acid Sequestrants | |
WO2010062863A2 | Compositions containing satiogens and methods of use | |
CA2744817A1 | Bile acid recycling inhibitors for treatment of obesity and diabetes | |
US2009264808A1 | Biliary/pancreatic shunt device and method for treatment of metabolic and other diseases |